Home > Insider Trading > Filing (0001140361-15-036229)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1428336	Healthequity Inc	HQY	Services-Business Services, Nec (7389)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352786	S Manu Rana	280 Park Avenue, 3Rd Floor New York NY 10017		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-25	1,150,000	$29.50	1,676,468	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$1.25		2021-10-25	7,500	7,500	Direct
Common Stock	Stock Option (right to buy)	$1.25		2022-04-26	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$1.50		2023-05-09	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$14.00	2015-01-31	2024-07-30	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$25.39		2025-03-26	15,000	15,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-10-25	7,500	7,500	Direct
2022-04-26	15,000	15,000	Direct
2023-05-09	15,000	15,000	Direct
2024-07-30	15,000	15,000	Direct
2025-03-26	15,000	15,000	Direct

Footnotes

Price of $29.50 does not reflect underwriter discount or fees.
All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
As previously reported in the reporting person's Form 3, the option grant had a $2.25 exercise price upon issuance. The $2.25 exercise price was automatically adjusted to $1.25 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
The option is immediately exercisable.
As previously reported in the reporting person's Form 3, the option grant had a $2.50 exercise price upon issuance. The $2.50 exercise price was automatically adjusted to $1.50 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2015 Annual Meeting of Stockholders held on June 24, 2015. The remaining 7,500 shares will become exercisable on January 31, 2016; provided, that the reporting person continues to serve as a director of the issuer through such date.